WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001023587) SERINE PROTEASE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/023587    International Application No.:    PCT/GB2000/003680
Publication Date: 05.04.2001 International Filing Date: 25.09.2000
IPC:
A61K 38/00 (2006.01), A61K 39/00 (2006.01), A61K 48/00 (2006.01), C12N 9/64 (2006.01)
Applicants: SMITHKLINE BEECHAM P.L.C. [GB/GB]; New Horizons Court, Brentford, Middlesex TW8 9EP (GB) (For All Designated States Except US).
SOUTHAN, Christopher, Donald [GB/GB]; (GB) (For US Only)
Inventors: SOUTHAN, Christopher, Donald; (GB)
Agent: CONNELL, Anthony, Christopher; Corporate Intellectual Property, SmithKline Beecham, Two New Horizons Court, Brentford, Middlesex TW8 9EP (GB)
Priority Data:
9922835.5 25.09.1999 GB
Title (EN) SERINE PROTEASE
(FR) NOUVEAU COMPOSE
Abstract: front page image
(EN)HETAA37 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing HETAA37 polypeptides and polynucleotides in the design of protocols for the treatment of cancer, inflammation, asthma, wasting diseases, atherosclerosis, stroke, diabetes, arthritis, Alzheimer's and other neurodegenerative diseases, and other neurological disorders, among others, and diagnostic assays for such conditions.
(FR)L'invention concerne des polypeptides et des polynucléotides HETAA37, ainsi que des procédés de production de ces polypeptides par des techniques recombinantes. L'invention concerne également des procédés d'utilisation des polypeptides et des polynucléotides HETAA37, dans la conception de protocoles de traitement du cancer, d'inflammations, de l'asthme, d'affections cachectisantes, de l'athérosclérose, des accidents cérébrovasculaires, du diabète, de l'arthrite, de la maladie d'Alzheimer d'autres affections neurodégénératives, et d'autres troubles neurologiques, entre autres, et enfin des tests de diagnostic pour les conditions décrites ci-dessus.
Designated States: JP, US.
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE).
Publication Language: English (EN)
Filing Language: English (EN)